Device Debuts is a regular Medtech Insight feature highlighting new products introduced into the market for the first time, important new iterations of existing products, or launches of existing products into new markets. As summer ends and 2018 approaches, the medical meeting calendar is starting to become more crowded, and companies are taking advantage of these opportunities to address their customers with new product launches.
Boston Scientific Corp. announced the US launch of the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems on Sept. 25. Resonate devices are...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?